Molly Kay Macejko is a Cleveland, Ohio based nurse practitioner. Active license number of Molly Kay Macejko is APRN.CNP.0032395 for Acute Care in Ohio. Her current practice location is 9500 Euclid Ave, Cleveland. Patients can reach her at 216-444-2200. Molly Kay Macejko is NP and her NPI number (Unique professional ID assigned by NPPES) is 1336876259. Molly Kay Macejko has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Molly Kay Macejko speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1336876259
NPI Enumeration Date:
02 Aug, 2022
NPI Last Update On:
14 Oct, 2022
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Molly Kay Macejko are as mentioned below.
License Number
Specialization
State
Status
APRN.CNP.0032395
Acute Care
Ohio
Primary
RN368265
Registered Nurse
Ohio
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Molly Kay Macejko 3924 W 158th St, Cleveland, Ohio
Zip:
44111-4271
Phone Number:
330-402-1287
Patients can reach Molly Kay Macejko at 9500 Euclid Ave, Cleveland, Ohio or can call to book an appointment on 216-444-2200.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.